Tradestie Institutional Equity Comparison Engine

LCTX vs ENGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LCTX Overall Edge

LCTX Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Lineage Cell Therapeutics, Inc. (LCTX) driven by superior Valuation, Momentum & Technical while ENGN counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, LCTX trades at 30.7x Forward P/E with -280.3% operating margin (-61.0% YoY revenue) versus ENGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, LCTX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro) against ENGN sits in SURGE (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner LCTX
LCTX 30.7x vs ENGN N/M Fwd P/E
Growth & Margin Winner ENGN
Op Margin -280.3% vs 0.0% ยท YoY -61.0% vs +0.0%
Momentum & Technical Winner LCTX
1Y -53.7% vs -74.4% ยท 52W Pos 4% vs 3%
Options & Structure Winner ENGN
BREAKDOWN (100th %ile IV) vs SURGE (<1st %ile IV)
LCTX NYSE American
Lineage Cell Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$0.82
-2.21% 1D
Market Cap $212.1M
1M Return -13.82%
1Y Return -53.67%
Forward P/E 30.7x
Unified AI Score
58.9 / 100 HOLD
Tech 65.0 Fund 54.0 Flow 65.0 Mom 45.0
ENGN NASDAQ
enGene Holdings Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.76
-4.86% 1D
Market Cap $119.6M
1M Return +7.98%
1Y Return -74.42%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 15.0 Fund 46.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LCTX -53.67% ENGN -74.42% Spread: +20.75 pp (LCTX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LCTX TTM Op. Margin: -280.3% ENGN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LCTX vs ENGN. Trailing 12-month operating profitability (LCTX -280.3% vs ENGN 0.0%) and valuation multiples (LCTX 30.7x vs ENGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LCTX (8) vs ENGN (2)
Institutional Metric LCTX ENGN Criterion Row Winner
Market Capitalization Scale $212.1M $119.6M Larger Scale LCTX
Trailing P/E Ratio Valuation 30.7x N/M Lower Multiple LCTX
Forward P/E Ratio Valuation 30.7x N/M Lower Multiple LCTX
Revenue Growth (YoY) Growth -61.0% +0.0% Higher Growth ENGN
Operating Margin (TTM) Profitability -280.3% 0.0% Higher Margin ENGN
Net Profit Margin Profitability 16.2% 0.0% Higher Margin LCTX
Return on Equity (ROE) Capital Efficiency 4.3% -60.5% Higher ROE LCTX
52-Week Range Position Momentum 4% ($1โ€“$2) 3% ($1โ€“$12) Stronger Trend LCTX
Beta / 30D Volatility Risk Regime 1.36ฮฒ ยท 79% Vol 1.96ฮฒ ยท 143% Vol Lower Realized Risk LCTX
Unified Institutional Score Composite Signal 58.9 / 100 (HOLD) 41.7 / 100 (SELL) Higher Composite LCTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LCTX vs ENGN Buy Guide
LCTX BREAKDOWN
6d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live LCTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENGN SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ENGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LCTX nor ENGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.